Stay updated on TMB & Neoantigen Relationship in Melanoma & Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the TMB & Neoantigen Relationship in Melanoma & Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TMB & Neoantigen Relationship in Melanoma & Bladder Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page has been updated to reflect the submission of results, and the version has been upgraded from v2.15.0 to v2.15.2.
    Difference
    0.2%
    Check dated 2025-05-01T06:20:51.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The webpage has been updated to include new clinical data regarding the effectiveness of nivolumab and its combination with ipilimumab in bladder cancer patients, while removing several metrics related to response rates and survival evaluations.
    Difference
    8%
    Check dated 2025-04-24T01:00:27.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect new research focus on bladder cancer, including specific evaluations of treatment responses and survival metrics, while removing previous studies related to melanoma. Additionally, the principal investigator's name has been updated.
    Difference
    49%
    Check dated 2025-04-16T20:28:34.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The webpage has been updated to include new clinical evaluation metrics such as overall response rate, duration of response, progression-free survival, and overall survival, while removing previous definitions and evaluations related to response rate and PD-L1 expression.
    Difference
    8%
    Check dated 2025-04-09T13:47:17.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-02T00:05:51.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-24T22:55:12.000Z thumbnail image

Stay in the know with updates to TMB & Neoantigen Relationship in Melanoma & Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TMB & Neoantigen Relationship in Melanoma & Bladder Cancer Clinical Trial page.